Plus Therapeutics Inc Net Asset Quality Index
Plus Therapeutics Inc net asset quality index. Plus Therapeutics Inc (PSTV) has a Net Asset Quality Index of 38.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $14.03 Million minus total liabilities of $8.57 Million yields net assets of $5.46 Million. A higher index indicates a stronger, lower-leverage balance sheet. See PSTV net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Plus Therapeutics Inc (1998–2025)
Net asset quality index of Plus Therapeutics Inc from 1998 to 2025. This chart shows how Plus Therapeutics Inc's Net Asset Quality Index has evolved across 28 annual periods from 1998 to 2025. As of June 2026, the index stands at 38.9%, representing net assets of $5.46 Million against total assets of $14.03 Million USD. Check PSTV strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Plus Therapeutics Inc Net Asset Quality Index by Year (1998–2025)
Plus Therapeutics Inc net asset quality index by year from 1998 to 2025. The table below presents the year-by-year Net Asset Quality Index for Plus Therapeutics Inc from 1998 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PSTV company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 24.5% | $4.00 Million | $16.32 Million | $12.33 Million | ▲ +159.4 pp |
| 2024 | -134.9% | $-8.95 Million | $6.63 Million | $15.58 Million | ▼ -123.1 pp |
| 2023 | -11.8% | $-1.35 Million | $11.39 Million | $12.74 Million | ▼ -38.8 pp |
| 2022 | 27.0% | $6.45 Million | $23.87 Million | $17.42 Million | ▼ -22.3 pp |
| 2021 | 49.3% | $10.84 Million | $21.98 Million | $11.14 Million | ▲ +24.3 pp |
| 2020 | 25.0% | $3.03 Million | $12.11 Million | $9.07 Million | ▲ +20.0 pp |
| 2019 | 5.0% | $1.16 Million | $23.23 Million | $22.07 Million | ▼ -16.8 pp |
| 2018 | 21.8% | $5.22 Million | $23.99 Million | $18.77 Million | ▼ -19.3 pp |
| 2017 | 41.1% | $13.00 Million | $31.61 Million | $18.61 Million | ▲ +9.4 pp |
| 2016 | 31.7% | $10.99 Million | $34.61 Million | $23.62 Million | ▼ -0.6 pp |
| 2015 | 32.4% | $12.21 Million | $37.70 Million | $25.49 Million | ▲ +47.1 pp |
| 2014 | -14.7% | $-5.70 Million | $38.72 Million | $44.42 Million | ▼ -22.2 pp |
| 2013 | 7.4% | $3.13 Million | $42.06 Million | $38.93 Million | ▼ -7.5 pp |
| 2012 | 14.9% | $6.46 Million | $43.25 Million | $36.80 Million | ▼ -4.4 pp |
| 2011 | 19.3% | $9.95 Million | $51.53 Million | $41.59 Million | ▼ -15.2 pp |
| 2010 | 34.5% | $22.87 Million | $66.35 Million | $43.47 Million | ▲ +49.3 pp |
| 2009 | -14.8% | $-3.66 Million | $24.75 Million | $28.41 Million | ▲ +15.4 pp |
| 2008 | -30.1% | $-7.72 Million | $25.61 Million | $33.33 Million | ▲ +13.6 pp |
| 2007 | -43.7% | $-9.40 Million | $21.51 Million | $30.91 Million | ▼ -0.2 pp |
| 2006 | -43.5% | $-10.81 Million | $24.87 Million | $35.68 Million | ▼ -21.4 pp |
| 2005 | -22.1% | $-6.23 Million | $28.17 Million | $34.40 Million | ▼ -72.5 pp |
| 2004 | 50.4% | $12.83 Million | $25.47 Million | $12.64 Million | ▼ -2.7 pp |
| 2003 | 53.1% | $14.91 Million | $28.09 Million | $13.18 Million | ▼ -13.0 pp |
| 2002 | 66.1% | $26.00 Million | $39.32 Million | $13.32 Million | ▼ -23.1 pp |
| 2001 | 89.2% | $38.49 Million | $43.14 Million | $4.66 Million | ▼ -5.2 pp |
| 2000 | 94.4% | $49.34 Million | $52.27 Million | $2.93 Million | ▲ +204.6 pp |
| 1999 | -110.3% | $-6.15 Million | $5.58 Million | $11.72 Million | ▼ -120.8 pp |
| 1998 | 10.6% | $108.00K | $1.02 Million | $912.00K | — |